MITAPIVAT for Hereditary haemolytic anaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where MITAPIVAT was used for Hereditary haemolytic anaemia.
Most Reported Side Effects for MITAPIVAT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Haemoglobin decreased | 161 | 25.7% | 1 | 22 |
| Fatigue | 80 | 12.8% | 0 | 7 |
| Product dose omission issue | 65 | 10.4% | 0 | 14 |
| Arthralgia | 46 | 7.3% | 0 | 0 |
| Drug ineffective | 44 | 7.0% | 0 | 6 |
| Off label use | 44 | 7.0% | 0 | 14 |
| Headache | 42 | 6.7% | 0 | 3 |
| Back pain | 34 | 5.4% | 0 | 3 |
| Malaise | 32 | 5.1% | 1 | 3 |
| Dyspnoea | 30 | 4.8% | 0 | 5 |
| Asthenia | 29 | 4.6% | 0 | 4 |
| Covid-19 | 26 | 4.2% | 0 | 5 |
| Product dose omission in error | 26 | 4.2% | 0 | 2 |
| Pain | 24 | 3.8% | 1 | 1 |
| Dizziness | 21 | 3.4% | 0 | 1 |
Other Indications for MITAPIVAT
Pyruvate kinase deficiency anaemia (499)
Product used for unknown indication (56)
Haemolytic anaemia (7)
Sickle cell disease (7)
Thalassaemia beta (7)
Anaemia of chronic disease (5)
Thalassaemia alpha (5)